Xconomy: Raleigh-Durham top stories News, Articles and Opinions

Results for “”

Entry	Author	Date	Location
Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More	Frank Vinluan	03/15/19	National
FDA Clears Aerie’s Combo Glaucoma Drug, But Will it Sell?	Ben Fidler	03/13/19	New York
Drug-Price Watchdog ICER Dives into Trump-Fueled Pharma Rebate Debate	Alex Lash	03/13/19	National
The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski	Ben Fidler	03/11/19	National
Bio Roundup: Gottlieb Exits, Bristol Defends, Biogen Buys & More	Alex Lash	03/08/19	National
Two Years and Done: FDA Commissioner Gottlieb To Resign	Alex Lash	03/05/19	National
Precision Bio Preps IPO to Test “Off-the-Shelf” Cancer Cell Therapy	Frank Vinluan	03/04/19	Raleigh Durham
Privacy Watch: FTC, Facebook, EU, the Cloud Act, & More CA bills	Bernadette Tansey	03/04/19	San Francisco
SPECIAL REPORT: 2019 Biopharma Outlook – Facing an Uncertain Future	Corie Lok	03/01/19	National
Bio Roundup: Pharma in DC, Bristol-Cel in Trouble, Roche Gets A Spark	Ben Fidler	03/01/19	National
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away	Alex Lash	02/26/19	National
Oyster Point Gets $93M To Clear Up Dry Eye With a Nasal Spray	Ben Fidler	02/26/19	New York
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More	Frank Vinluan	02/22/19	National
Cloud Tech Firm Nasuni Takes in $25M in Telstra-Led Funding Round	Brian Dowling	02/19/19	Boston
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More	Alex Lash	02/15/19	National
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans	Ben Fidler	02/12/19	National
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More	Ben Fidler	02/08/19	National
Privacy Watch: Facebook Rebounds, But Privacy Concerns Accelerate	Bernadette Tansey	02/04/19	San Francisco
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More	Frank Vinluan	02/01/19	National
Equidate, Re-Named Forge Global, Boosts Series B to $85M	Bernadette Tansey	01/29/19	San Francisco
Norwest VC Eyes Waves of Change in A.I., Marketing, Cloud for 2019	Bernadette Tansey	01/28/19	San Francisco
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More	Alex Lash	01/25/19	National
Bio Roundup: Aimmune Drama, Shutdown Blues, Perlmutter Talks Cancer	Ben Fidler	01/18/19	National
Merck And The Future of Immuno-Oncology: A Chat With Roger Perlmutter	Ben Fidler	01/16/19	National
A VC’s Take: Global Volatility Hurts U.S. Venture Ecosystem	Bernadette Tansey	01/15/19	San Francisco
Tech Companies Share Shutdown Losses, With Little Chance of Back Pay	Bernadette Tansey	01/11/19	San Francisco
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More	Frank Vinluan	01/11/19	National
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More	Alex Lash	01/11/19	National
Uncertainty Grows for Biotech as Government, FDA Shutdown Drags On	Corie Lok	01/10/19	National
FAANG, Public Trust, Valuations, in 2019: The Read from Menlo Ventures	Bernadette Tansey	01/10/19	San Francisco
Page 1 of 25	next page »